The impact of laryngopharyngeal reflux on patient-reported quality of life

被引:58
作者
Carrau, RL
Khidr, A
Crawley, JA
Hillson, EM
Davis, JK
Pashos, CL
机构
[1] Hlth Econ Res & Qual Life Evaluat Sci, Abt Associates Clin Trials, Cambridge, MA 02138 USA
[2] Univ Pittsburgh, Med Ctr, Dept Otolaryngol, Pittsburgh, PA USA
[3] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA
[4] AstraZeneca LP, Wilmington, DE USA
关键词
laryngopharyngeal reflux; health-related quality of life; Short Form-36 health survey;
D O I
10.1097/00005537-200404000-00014
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/Hypothesis: The objectives were to assess patient-reported outcomes, specifically, the health-related quality of life of patients with laryngopharyngeal reflux, and to compare those reported levels with the health-related quality of life of patients with gastroesophageal reflux disease and a general population. Study Design: Prospective study. Methods: As part of a prospective study to validate a health-related quality of life instrument for laryngopharyngeal reflux, patient-reported data were collected before the initiation of therapy. Use of the Short Form-36 (SF-36), a generic instrument, allowed the health-related quality of life of the patients with laryngopharyngeal reflux to be compared with benchmarks existing for patients with gastroesophageal reflux disease and a general U.S. population. Results: The 117 patients with laryngopharyngeal reflux often reported multiple symptoms, most frequently, chronic throat-clearing (85.5%), globus (82.1%), and hoarseness (80.3%). Their mean health-related quality of life was statistically significantly worse than that of a general U.S. population in seven of the eight SF-36 domains. The most dramatic differences between patients with laryngopharyngeal reflux and the general population were in social functioning and bodily pain (P < .001). Mean scores for patients with laryngopharyngeal reflux were significantly lower than those for patients with gastroesophageal reflux disease in social functioning (P < .001) and vitality (P = .0017). In five of the six remaining domains, patients with laryngopharyngeal reflux reported lower mean scores than did patients with gastroesophageal reflux disease, but those differences were not statistically significant. Conclusion: The study's assessment of health-related quality of life suggests that laryngopharyngeal reflux has a significant negative impact on the lives of patients. Although its impact is similar in some respects to that of gastroesophageal reflux disease, laryngopharyngeal reflux has a more significant impact on patients' social functioning and vitality.
引用
收藏
页码:670 / 674
页数:5
相关论文
共 31 条
  • [1] Ahuja V, 1999, AM FAM PHYSICIAN, V60, P873
  • [2] [Anonymous], 1994, SF 36 PHYS MENTAL HL
  • [3] [Anonymous], 1995, Diagnosis and treatment of voice disorders
  • [4] The validity and reliability of the reflux finding score (RFS)
    Belafsky, PC
    Postma, GN
    Koufman, JA
    [J]. LARYNGOSCOPE, 2001, 111 (08) : 1313 - 1317
  • [5] Assessing outcomes for dysphonic patients
    Benninger, MS
    Ahuja, AS
    Gardner, G
    Grywalski, C
    [J]. JOURNAL OF VOICE, 1998, 12 (04) : 540 - 550
  • [6] BLAUGRUND J, 1996, CURR OPIN OTOLARYNGO, V4, P138
  • [7] Validation of a specific quality of life questionnaire for functional digestive disorders
    Chassany, O
    Marquis, P
    Scherrer, B
    Read, NW
    Finger, T
    Bergmann, JF
    Fraitag, B
    Geneve, J
    Caulin, C
    [J]. GUT, 1999, 44 (04) : 527 - 533
  • [8] Development of a health-related quality-of-life questionnaire for individuals with gastroesophageal reflux disease - A validation study
    Colwell, HH
    Mathias, SD
    Pasta, DJ
    Henning, JM
    Hunt, RH
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1999, 44 (07) : 1376 - 1383
  • [9] QUALITY-OF-LIFE IN PATIENTS WITH UPPER GASTROINTESTINAL SYMPTOMS - AN IMPROVED EVALUATION OF TREATMENT REGIMENS
    DIMENAS, E
    GLISE, H
    HALLERBACK, B
    HERNQVIST, H
    SVEDLUND, J
    WIKLUND, I
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1993, 28 (08) : 681 - 687
  • [10] Eisen GM, 1999, AM J GASTROENTEROL, V94, P2017